Abhimanyu Mahajan
@amahajanmd.bsky.social
Movement disorders neurologist and Associate Professor at the University of Cincinnati| Science. Clinical care. Education. Occasionally, Policy| Views are my own, not medical advice. 🧠
https://orcid.org/0000-0001-8807-6672
https://orcid.org/0000-0001-8807-6672
Today at 6 pm EST
AAN Movement disorders section spotlight featuring @michaelokun.bsky.social
Registration: aan.zoom.us/meeting/regi...
@aanmember.bsky.social
AAN Movement disorders section spotlight featuring @michaelokun.bsky.social
Registration: aan.zoom.us/meeting/regi...
@aanmember.bsky.social
November 6, 2025 at 8:43 PM
Today at 6 pm EST
AAN Movement disorders section spotlight featuring @michaelokun.bsky.social
Registration: aan.zoom.us/meeting/regi...
@aanmember.bsky.social
AAN Movement disorders section spotlight featuring @michaelokun.bsky.social
Registration: aan.zoom.us/meeting/regi...
@aanmember.bsky.social
The AAN Movement Disorders Section Spotlight: Mid-career Neurologists in Academic Medicine by Dr. Michael Okun @michaelokun.bsky.social
When: 11/6/25, 6 pm EST
Target audience: All early and mid career neurologists, Division and department leadership
Register: aan.zoom.us/meeting/regi...
When: 11/6/25, 6 pm EST
Target audience: All early and mid career neurologists, Division and department leadership
Register: aan.zoom.us/meeting/regi...
October 11, 2025 at 3:01 PM
The AAN Movement Disorders Section Spotlight: Mid-career Neurologists in Academic Medicine by Dr. Michael Okun @michaelokun.bsky.social
When: 11/6/25, 6 pm EST
Target audience: All early and mid career neurologists, Division and department leadership
Register: aan.zoom.us/meeting/regi...
When: 11/6/25, 6 pm EST
Target audience: All early and mid career neurologists, Division and department leadership
Register: aan.zoom.us/meeting/regi...
The clinically and conceptually fascinating topic of Paroxysmal Movement Disorders.
Honored to contribute to the 2025 Movement disorders Continuum issue.
Thank you for the invitation Dr. @michaelokun.bsky.social and Dr. Lyell Jones.
Link: continuum.aan.com/doi/abs/10.1...
@aanmember.bsky.social
Honored to contribute to the 2025 Movement disorders Continuum issue.
Thank you for the invitation Dr. @michaelokun.bsky.social and Dr. Lyell Jones.
Link: continuum.aan.com/doi/abs/10.1...
@aanmember.bsky.social
August 1, 2025 at 1:31 PM
The clinically and conceptually fascinating topic of Paroxysmal Movement Disorders.
Honored to contribute to the 2025 Movement disorders Continuum issue.
Thank you for the invitation Dr. @michaelokun.bsky.social and Dr. Lyell Jones.
Link: continuum.aan.com/doi/abs/10.1...
@aanmember.bsky.social
Honored to contribute to the 2025 Movement disorders Continuum issue.
Thank you for the invitation Dr. @michaelokun.bsky.social and Dr. Lyell Jones.
Link: continuum.aan.com/doi/abs/10.1...
@aanmember.bsky.social
QEEG can identify neural changes even in early stages of cognitive decline and help differentiate etiologies.
Our review in Clinical Neurophysiology Practice covers fundamentals and focuses on applications.
Link to full text: doi.org/10.1016/j.cn...
Our review in Clinical Neurophysiology Practice covers fundamentals and focuses on applications.
Link to full text: doi.org/10.1016/j.cn...
July 4, 2025 at 6:59 PM
QEEG can identify neural changes even in early stages of cognitive decline and help differentiate etiologies.
Our review in Clinical Neurophysiology Practice covers fundamentals and focuses on applications.
Link to full text: doi.org/10.1016/j.cn...
Our review in Clinical Neurophysiology Practice covers fundamentals and focuses on applications.
Link to full text: doi.org/10.1016/j.cn...
When those who moved to private practice are asked if they miss academia..
Featuring Former Jedi Baylan Skoll (Ahsoka S1E6)
Featuring Former Jedi Baylan Skoll (Ahsoka S1E6)
May 13, 2025 at 1:38 AM
When those who moved to private practice are asked if they miss academia..
Featuring Former Jedi Baylan Skoll (Ahsoka S1E6)
Featuring Former Jedi Baylan Skoll (Ahsoka S1E6)
Great to visit @michiganstateu.bsky.social, meet with trainees, old friends and present grand rounds on our work in the intersection of cognitive and autonomic domains.
April 25, 2025 at 4:12 PM
Great to visit @michiganstateu.bsky.social, meet with trainees, old friends and present grand rounds on our work in the intersection of cognitive and autonomic domains.
Can cognitively unimpaired PD patients experience fluctuations in cognition and mood with dopamine replacement?
Yes: analysis reveals greater odds of fluctuations in anxiety (OR 7.5) and cognition (OR 2.8) with autonomic burden.
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
Yes: analysis reveals greater odds of fluctuations in anxiety (OR 7.5) and cognition (OR 2.8) with autonomic burden.
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
April 25, 2025 at 10:20 AM
Can cognitively unimpaired PD patients experience fluctuations in cognition and mood with dopamine replacement?
Yes: analysis reveals greater odds of fluctuations in anxiety (OR 7.5) and cognition (OR 2.8) with autonomic burden.
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
Yes: analysis reveals greater odds of fluctuations in anxiety (OR 7.5) and cognition (OR 2.8) with autonomic burden.
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
Dr. @elisabethbik.bsky.social presenting at UC Neurology grand rounds today on the fascinating topic of Errors and Misconduct in Biomedical Research.
From patterns on bathroom tiles to western blots.
From patterns on bathroom tiles to western blots.
April 16, 2025 at 4:15 PM
Dr. @elisabethbik.bsky.social presenting at UC Neurology grand rounds today on the fascinating topic of Errors and Misconduct in Biomedical Research.
From patterns on bathroom tiles to western blots.
From patterns on bathroom tiles to western blots.
It was fun and informative to chat with Dr. Sagari Bette on the neurology job hunt. Particularly interesting to learn from Dr. Anant Wadhwa, a movement disorders neurologist in a non-academic position in Boise, ID.
@sara-schaefer-md.bsky.social
Link: www.buzzsprout.com/1932303/epis...
@sara-schaefer-md.bsky.social
Link: www.buzzsprout.com/1932303/epis...
April 14, 2025 at 4:18 PM
It was fun and informative to chat with Dr. Sagari Bette on the neurology job hunt. Particularly interesting to learn from Dr. Anant Wadhwa, a movement disorders neurologist in a non-academic position in Boise, ID.
@sara-schaefer-md.bsky.social
Link: www.buzzsprout.com/1932303/epis...
@sara-schaefer-md.bsky.social
Link: www.buzzsprout.com/1932303/epis...
AI in clinical care?
Lots of news but with such influence, comes responsibility. Evidence for unmonitored use must pass a high bar of scrutiny.
Prof. Lees and I share our viewpoint and a wishlist.
Link to full text: movementdisorders.onlinelibrary.wiley.com/doi/full/10....
Lots of news but with such influence, comes responsibility. Evidence for unmonitored use must pass a high bar of scrutiny.
Prof. Lees and I share our viewpoint and a wishlist.
Link to full text: movementdisorders.onlinelibrary.wiley.com/doi/full/10....
March 20, 2025 at 11:05 AM
AI in clinical care?
Lots of news but with such influence, comes responsibility. Evidence for unmonitored use must pass a high bar of scrutiny.
Prof. Lees and I share our viewpoint and a wishlist.
Link to full text: movementdisorders.onlinelibrary.wiley.com/doi/full/10....
Lots of news but with such influence, comes responsibility. Evidence for unmonitored use must pass a high bar of scrutiny.
Prof. Lees and I share our viewpoint and a wishlist.
Link to full text: movementdisorders.onlinelibrary.wiley.com/doi/full/10....
If you are a senior resident, fellow and/ or a first time attendee to #AANAM
➡️Browse the app
➡️Email ppl to set up meetings
➡️Walk up to people and say hello
➡️Practice a 1 min intro
➡️Update CV
➡️Find out where the coffee is
➡️Wear comfy shoes
Any others?
P.S. 23 days to go
@aanmember.bsky.social
➡️Browse the app
➡️Email ppl to set up meetings
➡️Walk up to people and say hello
➡️Practice a 1 min intro
➡️Update CV
➡️Find out where the coffee is
➡️Wear comfy shoes
Any others?
P.S. 23 days to go
@aanmember.bsky.social
March 13, 2025 at 12:12 AM
If you are a senior resident, fellow and/ or a first time attendee to #AANAM
➡️Browse the app
➡️Email ppl to set up meetings
➡️Walk up to people and say hello
➡️Practice a 1 min intro
➡️Update CV
➡️Find out where the coffee is
➡️Wear comfy shoes
Any others?
P.S. 23 days to go
@aanmember.bsky.social
➡️Browse the app
➡️Email ppl to set up meetings
➡️Walk up to people and say hello
➡️Practice a 1 min intro
➡️Update CV
➡️Find out where the coffee is
➡️Wear comfy shoes
Any others?
P.S. 23 days to go
@aanmember.bsky.social
Happening now.. Dr. Steven Frucht speaking on focal task specific dystonia.
Link to weekly lecture series: mailchi.mp/e94a6a9a7eb0...
Link to weekly lecture series: mailchi.mp/e94a6a9a7eb0...
March 7, 2025 at 1:16 AM
Happening now.. Dr. Steven Frucht speaking on focal task specific dystonia.
Link to weekly lecture series: mailchi.mp/e94a6a9a7eb0...
Link to weekly lecture series: mailchi.mp/e94a6a9a7eb0...
Join us at #AANAM on Sunday, April 6th at 7 am as we cover updates in
🧠Pharmacological therapeutics (yours truly)
🧠DBS/ FUS (Dr. Fiorella Contarino) and
🧠AI (Dr. Deik) in movement disorders in 30 mins each!
Link: www.aan.com/msa/Public/E...
@aanmember.bsky.social
🧠Pharmacological therapeutics (yours truly)
🧠DBS/ FUS (Dr. Fiorella Contarino) and
🧠AI (Dr. Deik) in movement disorders in 30 mins each!
Link: www.aan.com/msa/Public/E...
@aanmember.bsky.social
February 20, 2025 at 12:11 AM
Join us at #AANAM on Sunday, April 6th at 7 am as we cover updates in
🧠Pharmacological therapeutics (yours truly)
🧠DBS/ FUS (Dr. Fiorella Contarino) and
🧠AI (Dr. Deik) in movement disorders in 30 mins each!
Link: www.aan.com/msa/Public/E...
@aanmember.bsky.social
🧠Pharmacological therapeutics (yours truly)
🧠DBS/ FUS (Dr. Fiorella Contarino) and
🧠AI (Dr. Deik) in movement disorders in 30 mins each!
Link: www.aan.com/msa/Public/E...
@aanmember.bsky.social
Fellows are under no obligation to bring back delicious souvenirs from fancy vacations..
February 18, 2025 at 6:35 PM
Fellows are under no obligation to bring back delicious souvenirs from fancy vacations..
From a few months ago..
February 13, 2025 at 1:09 PM
From a few months ago..
All that jerks is not myoclonus, not all who needle find benefit.
Our editorial on the new IAPRD myoclonus classification is online.
@albertoespay.bsky.social
www.prd-journal.com/article/S135...
Our editorial on the new IAPRD myoclonus classification is online.
@albertoespay.bsky.social
www.prd-journal.com/article/S135...
January 21, 2025 at 10:00 PM
All that jerks is not myoclonus, not all who needle find benefit.
Our editorial on the new IAPRD myoclonus classification is online.
@albertoespay.bsky.social
www.prd-journal.com/article/S135...
Our editorial on the new IAPRD myoclonus classification is online.
@albertoespay.bsky.social
www.prd-journal.com/article/S135...
Does exercise have a dose-dependent impact on cognition in PD?
Our work led by Dr. Seemiller is now online.
Physical activity levels associate with cognitive performance in both OFF- and ON- states. Small amounts of physical activity can benefit cognition.
www.prd-journal.com/article/S135...
Our work led by Dr. Seemiller is now online.
Physical activity levels associate with cognitive performance in both OFF- and ON- states. Small amounts of physical activity can benefit cognition.
www.prd-journal.com/article/S135...
January 13, 2025 at 9:46 AM
Does exercise have a dose-dependent impact on cognition in PD?
Our work led by Dr. Seemiller is now online.
Physical activity levels associate with cognitive performance in both OFF- and ON- states. Small amounts of physical activity can benefit cognition.
www.prd-journal.com/article/S135...
Our work led by Dr. Seemiller is now online.
Physical activity levels associate with cognitive performance in both OFF- and ON- states. Small amounts of physical activity can benefit cognition.
www.prd-journal.com/article/S135...
What does a positive αSyn-SAA mean?
✅It supports a Parkinson's diagnosis.
✅It does not indicate disease mechanisms, severity, progression rate, biological subtypes, or treatment response.
Important article: www.sciencedirect.com/science/arti...
@albertoespay.bsky.social @ajlees.bsky.social
✅It supports a Parkinson's diagnosis.
✅It does not indicate disease mechanisms, severity, progression rate, biological subtypes, or treatment response.
Important article: www.sciencedirect.com/science/arti...
@albertoespay.bsky.social @ajlees.bsky.social
December 30, 2024 at 4:02 AM
What does a positive αSyn-SAA mean?
✅It supports a Parkinson's diagnosis.
✅It does not indicate disease mechanisms, severity, progression rate, biological subtypes, or treatment response.
Important article: www.sciencedirect.com/science/arti...
@albertoespay.bsky.social @ajlees.bsky.social
✅It supports a Parkinson's diagnosis.
✅It does not indicate disease mechanisms, severity, progression rate, biological subtypes, or treatment response.
Important article: www.sciencedirect.com/science/arti...
@albertoespay.bsky.social @ajlees.bsky.social
Students, trainees and practicing neurologists: here is a list of conferences relevant for movement disorders education to choose from in 2025.
December 29, 2024 at 11:02 AM
Students, trainees and practicing neurologists: here is a list of conferences relevant for movement disorders education to choose from in 2025.
Is orthostatic hypotension (OH) a cause of daytime sleepiness in PD?
Our analysis shows no association in an early, treated cohort. However, in those cognitively impaired, OH has an interesting, complex expression with daytime sleepiness via depression.
Link: www.sciencedirect.com/science/arti...
Our analysis shows no association in an early, treated cohort. However, in those cognitively impaired, OH has an interesting, complex expression with daytime sleepiness via depression.
Link: www.sciencedirect.com/science/arti...
December 24, 2024 at 5:20 PM
Is orthostatic hypotension (OH) a cause of daytime sleepiness in PD?
Our analysis shows no association in an early, treated cohort. However, in those cognitively impaired, OH has an interesting, complex expression with daytime sleepiness via depression.
Link: www.sciencedirect.com/science/arti...
Our analysis shows no association in an early, treated cohort. However, in those cognitively impaired, OH has an interesting, complex expression with daytime sleepiness via depression.
Link: www.sciencedirect.com/science/arti...
Cool MEG study on oscillatory slowing and functional connectivity differences before cognitive impairment in individuals
11 cognitively unimpaired individuals with pathogenic mutations in the presenilin-1 or APP gene and a 1:3 matched control group
Link: academic.oup.com/braincomms/a...
11 cognitively unimpaired individuals with pathogenic mutations in the presenilin-1 or APP gene and a 1:3 matched control group
Link: academic.oup.com/braincomms/a...
December 23, 2024 at 9:28 AM
Cool MEG study on oscillatory slowing and functional connectivity differences before cognitive impairment in individuals
11 cognitively unimpaired individuals with pathogenic mutations in the presenilin-1 or APP gene and a 1:3 matched control group
Link: academic.oup.com/braincomms/a...
11 cognitively unimpaired individuals with pathogenic mutations in the presenilin-1 or APP gene and a 1:3 matched control group
Link: academic.oup.com/braincomms/a...
December 20, 2024 at 11:51 PM
🧠Honored to be elected as Chair of the AAN Movement disorders section from 2025-2027. Let’s go! 🧠
@aanmember.bsky.social
@aanmember.bsky.social
December 20, 2024 at 8:32 PM
🧠Honored to be elected as Chair of the AAN Movement disorders section from 2025-2027. Let’s go! 🧠
@aanmember.bsky.social
@aanmember.bsky.social
Vascular Neurology Considerations for Antiamyloid Immunotherapy: Science Advisory from American Heart Association. Affirmed by AAN.
❌Anticoagulants: exclude from immunotherapy
❌Thrombolytics: avoid until date demonstrating safety are available
Link: www.ahajournals.org/doi/epdf/10....
❌Anticoagulants: exclude from immunotherapy
❌Thrombolytics: avoid until date demonstrating safety are available
Link: www.ahajournals.org/doi/epdf/10....
December 11, 2024 at 11:41 PM
Vascular Neurology Considerations for Antiamyloid Immunotherapy: Science Advisory from American Heart Association. Affirmed by AAN.
❌Anticoagulants: exclude from immunotherapy
❌Thrombolytics: avoid until date demonstrating safety are available
Link: www.ahajournals.org/doi/epdf/10....
❌Anticoagulants: exclude from immunotherapy
❌Thrombolytics: avoid until date demonstrating safety are available
Link: www.ahajournals.org/doi/epdf/10....
Neuronal ceroid lipofuscinoses
✅Seizures (75%), milestone regression (87.5%), visual impairment (34%), ataxia (57%)
✅Median onset: 36 months, duration: 65.5 months
✅8 genetic subtypes
✅Cerebellar atrophy in 89%, thalamic T2 hypo-intensity in 91%
www.jns-journal.com/article/S002...
✅Seizures (75%), milestone regression (87.5%), visual impairment (34%), ataxia (57%)
✅Median onset: 36 months, duration: 65.5 months
✅8 genetic subtypes
✅Cerebellar atrophy in 89%, thalamic T2 hypo-intensity in 91%
www.jns-journal.com/article/S002...
December 11, 2024 at 7:19 PM
Neuronal ceroid lipofuscinoses
✅Seizures (75%), milestone regression (87.5%), visual impairment (34%), ataxia (57%)
✅Median onset: 36 months, duration: 65.5 months
✅8 genetic subtypes
✅Cerebellar atrophy in 89%, thalamic T2 hypo-intensity in 91%
www.jns-journal.com/article/S002...
✅Seizures (75%), milestone regression (87.5%), visual impairment (34%), ataxia (57%)
✅Median onset: 36 months, duration: 65.5 months
✅8 genetic subtypes
✅Cerebellar atrophy in 89%, thalamic T2 hypo-intensity in 91%
www.jns-journal.com/article/S002...